» Articles » PMID: 6401776

Meningococcal Disease in South Australia: Incidence and Serogroup Distribution 1971-1980

Overview
Journal J Hyg (Lond)
Specialty Public Health
Date 1983 Feb 1
PMID 6401776
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

During the ten-year period 1971-80 isolates of meningococci from 85 cases of meningococcal disease (MD) in South Australia, from 66 children, 6 adolescents and 13 adults, were examined. These comprised 69 cases of meningitis and 16 cases of bacteraemia without meningitis. Thirty-three (39%) of all cases of MD occurred in children less than 1 year of age, the median age was 19 months. Serogroup B accounted for 61 (72%) cases of MD, group A seven (8%), group C seven (8%), group W135 five (6%), group Y three (4%) and group X one (1%); in addition there was a single case of Neisseria lactamica infection. The annual prevalence of MD in South Australia for the period was 11 cases per 100000 for children under the age of 2 years and 0.7 cases per 100000 overall. The prevalence was highest in winter (45% cases) and spring (26%) and lowest in summer (13%). The overall mortality rate was 8%. Four of the 21 infants under the age of 6 months died (mortality rate 19%) whereas none of the 32 children aged from 6 months to 14 years died (P = 0.02). Amongst the survivors, three children had deafness, which was bilateral and severe in two.

Citing Articles

Global Case Fatality of Bacterial Meningitis During an 80-Year Period: A Systematic Review and Meta-Analysis.

van Ettekoven C, Liechti F, Brouwer M, Bijlsma M, van de Beek D JAMA Netw Open. 2024; 7(8):e2424802.

PMID: 39093565 PMC: 11297475. DOI: 10.1001/jamanetworkopen.2024.24802.


Range of Clinical Manifestations Caused by Invasive Meningococcal Disease Due to Serogroup W: A Systematic Review.

Bertrand-Gerentes I, Fanchon L, Coste F, Glover R, Guiddir T, Taha M Infect Dis Ther. 2023; 12(10):2337-2351.

PMID: 37751017 PMC: 10600084. DOI: 10.1007/s40121-023-00869-z.


Genomic characterization of invasive meningococcal X isolates from Brazil, 1992-2022.

Cassiolato A, Camargo C, Piccoli Cecconi M, Christakis S, Goncalves C, Campos K Int Microbiol. 2023; 26(3):611-618.

PMID: 36626096 PMC: 9838296. DOI: 10.1007/s10123-023-00325-5.


A Narrative Review of the W, X, Y, E, and NG of Meningococcal Disease: Emerging Capsular Groups, Pathotypes, and Global Control.

Tzeng Y, Stephens D Microorganisms. 2021; 9(3).

PMID: 33802567 PMC: 7999845. DOI: 10.3390/microorganisms9030519.


Differences in the population structure of Neisseria meningitidis in two Australian states: Victoria and Western Australia.

Mowlaboccus S, Mullally C, Richmond P, Howden B, Stevens K, Speers D PLoS One. 2017; 12(10):e0186839.

PMID: 29065137 PMC: 5655437. DOI: 10.1371/journal.pone.0186839.


References
1.
Gotschlich E, Goldschneider I, Artenstein M . Human immunity to the meningococcus. IV. Immunogenicity of group A and group C meningococcal polysaccharides in human volunteers. J Exp Med. 1969; 129(6):1367-84. PMC: 2138657. DOI: 10.1084/jem.129.6.1367. View

2.
Artenstein M, Gold R, Zimmerly J, Wyle F, Schneider H, Harkins C . Prevention of meningococcal disease by group C polysaccharide vaccine. N Engl J Med. 1970; 282(8):417-20. DOI: 10.1056/NEJM197002192820803. View

3.
Feldman H . Some recollections of the meningococcal diseases. The first Harry F. Dowling lecture. JAMA. 1972; 220(8):1107-12. View

4.
Souza de Morais J, MUNFORD R, RISI J, Antezana E, Feldman R . Epidemic disease due to serogroup C Neisseria meningitidis in Saõ Paulo, Brazil. J Infect Dis. 1974; 129(5):568-71. DOI: 10.1093/infdis/129.5.568. View

5.
Peltola H, Makela H, Kayhty H, Jousimies H, Herva E, HALLSTROM K . Clinical efficacy of meningococcus group A capsular polysaccharide vaccine in children three months to five years of age. N Engl J Med. 1977; 297(13):686-91. DOI: 10.1056/NEJM197709292971302. View